Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply. Alimentary pharmacology & therapeutics Lin, D. n., Yang, H. I., Hoang, J. n., Nguyen, M. H. 2017; 45 (1): 186–87

View details for PubMedID 27910142